Using a genetic test result in the care of family members: how does the duty of confidentiality apply
Using a genetic test result in the care of family members: how does the duty of confidentiality apply
The use of genetic and genomic testing is becoming more widespread in healthcare and more inherited explanations for family history of diseases or conditions are being uncovered. Currently, relevant genetic information is not always used in the care of family members who might benefit from it, because of health professionals' fears of inappropriately breaching another family member's confidence. Such examples are likely to increase as testing possibilities expand. Here we present the case for use of familial information in the care and treatment of family members. We argue that whilst a clinical diagnosis in person A is confidential, the discovery of a familial factor that led to this diagnosis should be available for use in depersonalised form by health professionals to inform the testing and clinical care of other family members. The possibility of such use should be made clear in clinical practice at the time of initial testing, but should not require consent from the person in whom the familial factor was first identified. We call for further debate on these questions in the wake of high profile non-disclosure of genetic information cases, and forthcoming Data Protection legislation changes
955-959
Parker, Michael
d012a2b8-d4f7-49c1-beca-d69705c2ee43
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
July 2018
Parker, Michael
d012a2b8-d4f7-49c1-beca-d69705c2ee43
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Parker, Michael and Lucassen, Anneke
(2018)
Using a genetic test result in the care of family members: how does the duty of confidentiality apply.
European Journal of Human Genetics, 26 (7), .
(doi:10.1038/s41431-018-0138-y).
Abstract
The use of genetic and genomic testing is becoming more widespread in healthcare and more inherited explanations for family history of diseases or conditions are being uncovered. Currently, relevant genetic information is not always used in the care of family members who might benefit from it, because of health professionals' fears of inappropriately breaching another family member's confidence. Such examples are likely to increase as testing possibilities expand. Here we present the case for use of familial information in the care and treatment of family members. We argue that whilst a clinical diagnosis in person A is confidential, the discovery of a familial factor that led to this diagnosis should be available for use in depersonalised form by health professionals to inform the testing and clinical care of other family members. The possibility of such use should be made clear in clinical practice at the time of initial testing, but should not require consent from the person in whom the familial factor was first identified. We call for further debate on these questions in the wake of high profile non-disclosure of genetic information cases, and forthcoming Data Protection legislation changes
Text
s41431-018-0138-y
- Version of Record
More information
Accepted/In Press date: 2 March 2018
e-pub ahead of print date: 27 April 2018
Published date: July 2018
Identifiers
Local EPrints ID: 420334
URI: http://eprints.soton.ac.uk/id/eprint/420334
ISSN: 1018-4813
PURE UUID: e358f045-86d1-4005-b573-61eccaec02bc
Catalogue record
Date deposited: 04 May 2018 16:30
Last modified: 16 Mar 2024 03:23
Export record
Altmetrics
Contributors
Author:
Michael Parker
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics